Evaluation of the Renal Injury from Gold Salts and Nonsteroidal Anti-inflammatory Drugs in Patients with Rheumatoid Arthritis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The urinary excretion of proteins, N-acetyl-3-glucosaminidase and leucine aminopeptidase, was measured in 50 patients with rheumatoid arthritis (RA), of whom 20 subjects were on nonsteroidal anti-inflammatory drugs (NSAIDs) and 30 on gold salts. No pathological changes of the above-mentioned urinary parameters have been observed in the group of RA patients, in comparison with control subjects and patients suffering from osteoarthritis treated with NSAIDs.
References
1.
Merle L, Reidenberg M, Camacho M, Jones B, Drayer D
. Renal injury in patients with rheumatoid arthritis treated with gold. Clin Pharmacol Ther. 1980; 28(2):216-22.
DOI: 10.1038/clpt.1980.153.
View
2.
Reeves W, Foley R, Weinman E
. Renal dysfunction from nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1984; 144(10):1943-4.
DOI: 10.1001/archinte.144.10.1943.
View
3.
Clemenzia G, LATERZA G, Russo G, Santini P, Scibinetti F, Gentile V
. [Normal values of the urinary activity of 4 enzymes]. Minerva Med. 1984; 75(43):2591-6.
View
4.
Fox D, Jick H
. Nonsteroidal anti-inflammatory drugs and renal disease. JAMA. 1984; 251(10):1299-300.
View
5.
. Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial. Ann Rheum Dis. 1961; 20(4):315-34.
PMC: 1007231.
DOI: 10.1136/ard.20.4.315.
View